Skip to main content
AkademIndex

Products

For developers

AkademBaseOpen API for the ecosystem

Ying Zhang

1 works

Current affiliation: State Key Laboratory of Drug Research, Molecular Imaging Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China

  1. The combination of calreticulin-targeting L-ASNase and anti-PD-L1 antibody modulates the tumor immune microenvironment to synergistically enhance the antitumor efficacy of radiotherapy

    Ying Zhang, V. Akhil, Ho Seong Seo +8

    ArticleCancer Research and TreatmentsTheranostics20240 citations
    ABI